GOVX Stock Analysis: Buy, Sell, or Hold?
GOVX - GeoVax Labs, Inc. New
$2.03
-0.07 (-3.33%)
▼
5d:
-23.97%
30d:
+59.84%
90d:
+18.71%
HOLD
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Get Alerted When GOVX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
7 traders called GOVX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GOVX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: GOVX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: GOVX is currently trading at $2.03, which is considered slightly high relative to its 30-day fair value range of $1.05 to $2.49.
Technical Outlook: Technically, GOVX is in a downtrend. Immediate support is located at $1.83, while resistance sits at $4.31. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+392.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GOVX is in a downtrend. Immediate support is located at $1.83, while resistance sits at $4.31. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+392.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$1.05 -
$2.49
Company Quality Score
52/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
56.3%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-3.3%)
- BULLISH: Trading 392.6% below Wall St target ($10.00)
- CAUTION: 5-day price weakness (-24.0%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.05 -
$2.49
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.83
Resistance Level
$4.31
Current Trend
Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.66
Wall Street Target
$10.00
(+392.6%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: June 04, 2026 3:09 AM ET
Data refreshes hourly during market hours. Next update: 4:09 AM
Data refreshes hourly during market hours. Next update: 4:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GOVX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 54 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 62 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$123 | 50 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 52 HOLD |
